ALLMedicine™ Acute Cholangitis Center
Research & Reviews 233 results
https://doi.org/10.1177/15533506231162995
Surgical Innovation; Lyu Y, Ye S et. al.
Mar 11th, 2023 - Acute cholangitis (AC) is a common emergency with a significant mortality risk. This study aimed to compare urgent, early, and late endoscopic retrograde cholangiopancreatography (ERCP) for AC. We retrospectively evaluated patients diagnosed with ...
https://clinicaltrials.gov/ct2/show/NCT05750966
Mar 2nd, 2023 - Acute cholangitis is an infection of the biliary tract which is managed with biliary drainage and antibiotic therapy (ABT). Currently the international Tokyo Guidelines 2018 (TG18) recommend 4 to 7 days of ABT after source control. The national SW...
https://clinicaltrials.gov/ct2/show/NCT03921502
Mar 1st, 2023 - Introduction Cholelithiasis occurs in 10-20% of the general population (1). Up to 18% of these subjects will present symptoms and, of these, 1.5% will present an episode of pancreatitis, cholecystitis or acute cholangitis (2). In this way, the pat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932428
World Journal of Gastroenterology; Yang J, Liu Y et. al.
Feb 24th, 2023 - Severe acute cholangitis (AC) exacerbates the risk of death because of the rapid progression of the disease. The optimal timing of biliary decompression (BD) as a necessary intervention in patients with severe AC is controversial. A recently repor...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896617
World Journal of Gastroenterology; Adekunle AD, Rubens M et. al.
Feb 7th, 2023 - The impact of the coronavirus on hospitalizations for gastrointestinal (GI) disease, particularly at a population level is understudied. To investigate trends in hospitalizations, inpatient endoscopy resource utilization, and outcomes during the f...
Guidelines 7 results
https://doi.org/10.1016/j.jacr.2019.02.020
Journal of the American College of Radiology : JACR; , Fairchild AH et. al.
May 6th, 2019 - Biliary obstruction is a serious condition that can occur in the setting of both benign and malignant pathologies. In the setting of acute cholangitis, biliary decompression can be lifesaving; for patients with cancer who are receiving chemotherap...
https://doi.org/10.1055/a-0862-0346
Endoscopy Manes G, Paspatis G et. al.
Apr 4th, 2019 - ESGE recommends offering stone extraction to all patients with common bile duct stones, symptomatic or not, who are fit enough to tolerate the intervention.Strong recommendation, low quality evidence.ESGE recommends liver function tests and abdomi...
https://doi.org/10.1007/s00534-012-0572-0
Journal of Hepato-biliary-pancreatic Sciences; Gomi H, Solomkin JS et. al.
Jan 24th, 2013 - Therapy with appropriate antimicrobial agents is an important component in the management of patients with acute cholangitis and/or acute cholecystitis. In the updated Tokyo Guidelines (TG13), we recommend antimicrobial agents that are suitable fr...
https://doi.org/10.1007/s00534-012-0563-1
Journal of Hepato-biliary-pancreatic Sciences; Miura F, Takada T et. al.
Jan 12th, 2013 - We propose a management strategy for acute cholangitis and cholecystitis according to the severity assessment. For Grade I (mild) acute cholangitis, initial medical treatment including the use of antimicrobial agents may be sufficient for most cas...
https://doi.org/10.1007/s00534-012-0566-y
Journal of Hepato-biliary-pancreatic Sciences; Takada T, Strasberg SM et. al.
Jan 12th, 2013 - In 2007, the Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) were first published in the Journal of Hepato-Biliary-Pancreatic Surgery. The fundamental policy of TG07 was to achieve the objectives of TG07 through t...
Clinicaltrials.gov 21 results
https://clinicaltrials.gov/ct2/show/NCT05750966
Mar 2nd, 2023 - Acute cholangitis is an infection of the biliary tract which is managed with biliary drainage and antibiotic therapy (ABT). Currently the international Tokyo Guidelines 2018 (TG18) recommend 4 to 7 days of ABT after source control. The national SW...
https://clinicaltrials.gov/ct2/show/NCT03921502
Mar 1st, 2023 - Introduction Cholelithiasis occurs in 10-20% of the general population (1). Up to 18% of these subjects will present symptoms and, of these, 1.5% will present an episode of pancreatitis, cholecystitis or acute cholangitis (2). In this way, the pat...
https://clinicaltrials.gov/ct2/show/NCT05611840
Feb 2nd, 2023 - Background (i) Background information Gallstone disease is a very common disease identity in developed countries, causing a major health burden. There is an estimate of 20 - 25 million adults diagnosed to have gallstone disease annually, resulting...
https://clinicaltrials.gov/ct2/show/NCT04503291
Jul 22nd, 2022 - If surgical treatment is not possible in patients with malignant obstruction in the common bile duct, endoscopic metal stent placement to resolve biliary obstruction is a standard treatment that is commonly performed. The metal stents relieve the ...
https://clinicaltrials.gov/ct2/show/NCT03155321
Apr 7th, 2022 - The study is based on an anonymous questionnaire that is distributed among polish surgeons across the country. The questionnaire focuses on the demographic data of the surgeon, their experience in years, a few questions regarding their experience ...
News 4 results
https://www.medscape.com/viewarticle/974779
May 27th, 2022 - Patients with acute cholangitis are twice as likely to be readmitted within 30 days if they don't get a cholecystectomy in the same hospital admission for which they get biliary decompression, researchers say. The readmissions result mostly from s...
https://www.mdedge.com/gihepnews/article/129915/general-surgery/interval-cholecystectomy-may-be-risky-business
Michele G. Sullivan, MDedge News
Jan 24th, 2017 - HOLLYWOOD, FLA – Interval cholecystectomy remains a challenging procedure, with longer operative times and ICU stays, greater blood loss, more biliary and bowel injuries, and even hints of increased mortality, compared with immediate cholecystecto.
https://www.medscape.com/viewarticle/762763_4
May 2nd, 2012 - Treatment of Caroli Disease Medical therapy is geared toward reducing the incidence of intrahepatic stones. Oral ursodeoxycholic acid has been shown to have some efficacy in reducing cholesterol stone formation and bile stagnation by increasing bi...
https://www.medscape.com/viewarticle/405156_3
Nov 9th, 2001 - Discussion RPC, often referred to as Oriental cholangiohepatitis, is a progressive, destructive cholangiopathy of unknown cause. Although parasites are generally cultured from the bile and blood of patients with RPC during episodes of acute cholan...